Commentary

Evaluating the impact of FDA’s pregnancy and lactation labeling rule


 

Dr. Chambers is a professor of pediatrics and director of clinical research at Rady Children’s Hospital, and associate director of the Clinical and Translational Research Institute at the University of California, San Diego. She is director of MotherToBaby California, a past president of the Organization of Teratology Information Specialists, and past president of the Teratology Society. She has no relevant financial disclosures. To comment, e-mail her at obnews@frontlinemedcom.com.

Pages

Recommended Reading

Large study shows no link between celiac disease and fertility problems
MDedge Family Medicine
Kidney donors at greater risk of preeclampsia, gestational hypertension
MDedge Family Medicine
Link between early exposure to acetaminophen and childhood asthma found weak, overstated
MDedge Family Medicine
Exclusively breastfed neonate weight loss graphed
MDedge Family Medicine
VIDEO: Family physicians can fill rural maternity care gaps
MDedge Family Medicine
FDA issues new pregnancy/lactation drug label standards
MDedge Family Medicine
CDC seeks comment on draft circumcision guidance
MDedge Family Medicine
Consider biopsy for active lupus nephritis in pregnancy
MDedge Family Medicine
Watchful waiting is viable option for unruptured ectopic pregnancies
MDedge Family Medicine
Nearly 9% of Medicaid-financed births are early elective deliveries
MDedge Family Medicine

Related Articles